nach oben

European Journal of Nutrition

Erschienen in:

19.08.2015 | Original Contribution

In vitro fermentation of nuts results in the formation of butyrate and c9,t11 conjugated linoleic acid as chemopreventive metabolites

verfasst von: W. Schlörmann, M. Birringer, A. Lochner, S. Lorkowski, I. Richter, C. Rohrer, M. Glei

Erschienen in: European Journal of Nutrition | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The consumption of foods rich in dietary fiber and polyunsaturated fatty acids such as nuts can contribute to a healthy diet. Therefore, the formation of fermentation end-products which might exert chemopreventive effects regarding colon cancer was investigated after an in vitro simulated digestion and fermentation of nuts using human fecal microbiota.

Methods

Fermentation supernatants (FS) and pellets (FP) were obtained after an in vitro fermentation of hazelnuts, almonds, macadamia, pistachios and walnuts. Short-chain fatty acids (SCFA) and bile acids (BA) in FS as well as fatty acids in FP were analyzed via gas chromatography. Malondialdehyde (MDA) levels in FS were determined photometrically.

Results

Fermentation of nuts resulted in 1.9- to 2.8-fold higher concentrations of SCFA compared to the control and a shift of molar ratios toward butyrate production. In vitro fermentation resulted in the formation of vaccenic acid (C18:1t11, 32.1 ± 3.2 % FAME; fatty acid methyl ester) and conjugated linoleic acid (c9,t11 CLA, 2.4 ± 0.7 % FAME) exclusively in fermented walnut samples. Concentrations of secondary BA deoxycholic-/iso-deoxycholic acid (6.8–24.1-fold/4.9–10.9-fold, respectively) and levels of MDA (1.3-fold) were significantly reduced in fermented nut samples compared to the control.

Conclusion

This is the first study that demonstrates the ability of the human fecal microbiota to convert polyunsaturated fatty acids from walnuts to c9,t11 CLA as a potential chemopreventive metabolite. In addition, the production of butyrate and reduction in potential carcinogens such as secondary BA and lipid peroxidation products might contribute to the protective effects of nuts regarding colon cancer development.

Nur mit Berechtigung zugänglich

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:359–386CrossRef

Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA (2010) Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 138:877–885CrossRef

Hisamuddin IM, Yang VW (2004) Genetics of colorectal cancer. Med Gen Med 6:13

Slattery ML (2000) Diet, lifestyle, and colon cancer. Semin Gastrointest Dis 11:142–146

Jacobs ET, Thompson PA, Martinez ME (2007) Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 41:731–746CrossRef

Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Dahm CC, Overvad K, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Racine A, Kaaks R, Teucher B, Boeing H, Bergmann MM, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Pala V, Panico S, Tumino R, Vineis P, Siersema P, van Duijnhoven F, Peeters PH, Hjartaker A, Engeset D, Gonzalez CA, Sanchez MJ, Dorronsoro M, Navarro C, Ardanaz E, Quiros JR, Sonestedt E, Ericson U, Nilsson L, Palmqvist R, Khaw KT, Wareham N, Key TJ, Crowe FL, Fedirko V, Wark PA, Chuang SC, Riboli E (2012) Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC). PLoS ONE 7:e39361. doi:10.1371/journal.pone.0039361 CrossRef

Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:259–275CrossRef

Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012–1017

Ros E (2010) Health benefits of nut consumption. Nutrients 2:652–682CrossRef

10.

Gray J (2006) Dietary Fiber-definition, analysis, physiology and health. ILSI Europe`s Concise Monographs and Report Series. ILSI Europe a.i.s.b.l, Brussels, Belgium

11.

Jenab M, Ferrari P, Slimani N, Norat T, Casagrande C, Overad K, Olsen A, Stripp C, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Kesse E, Nieters A, Bergmann M, Boeing H, Naska A, Trichopoulou A, Palli D, Krogh V, Celentano E, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Ocke MC, Peeters PH, Engeset D, Quiros JR, Gonzalez CA, Martinez C, Chirlaque MD, Ardanaz E, Dorronsoro M, Wallstrom P, Palmqvist R, van Guelpen B, Bingham S, San Joaquin MA, Saracci R, Kaaks R, Riboli E (2004) Association of nut and seed intake with colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 13:1595–1603

12.

Yang M, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS, Wu K, Bao Y (2015) Nut consumption and risk of colorectal cancer in women. Eur J Clin Nutr. doi:10.1038/ejcn.2015.66

13.

Schlörmann W, Birringer M, Bohm V, Lober K, Jahreis G, Lorkowski S, Muller AK, Schone F, Glei M (2015) Influence of roasting conditions on health-related compounds in different nuts. Food Chem 180:77–85CrossRef

14.

Gebauer SK, Chardigny JM, Jakobsen MU, Lamarche B, Lock AL, Proctor SD, Baer DJ (2011) Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2:332–354CrossRef

15.

Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, Severson RK (2010) Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127:942–951

16.

Kuriki K, Wakai K, Hirose K, Matsuo K, Ito H, Suzuki T, Saito T, Kanemitsu Y, Hirai T, Kato T, Tatematsu M, Tajima K (2006) Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids. Cancer Epidemiol Biomarkers Prev 15:1791–1798CrossRef

17.

Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M, Becker W (2014) Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res 58:25145. doi:10.3402/fnr.v58.25145 CrossRef

18.

Kuhnt K, Kraft J, Moeckel P, Jahreis G (2006) Trans-11-18:1 is effectively Delta9-desaturated compared with trans-12-18: 1 in humans. Br J Nutr 95:752–761CrossRef

19.

Degen C, Ecker J, Piegholdt S, Liebisch G, Schmitz G, Jahreis G (2011) Metabolic and growth inhibitory effects of conjugated fatty acids in the cell line HT-29 with special regard to the conversion of t11, t13-CLA. Biochim Biophys Acta 1811:1070–1080CrossRef

20.

Palombo JD, Ganguly A, Bistrian BR, Menard MP (2002) The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett 177:163–172CrossRef

21.

Degen C, Habermann N, Piegholdt S, Glei M, Jahreis G (2012) Human colon cell culture models of different transformation stages to assess conjugated linoleic acid and conjugated linolenic acid metabolism: challenges and chances. Toxicol In Vitro 26:985–992CrossRef

22.

Lux S, Scharlau D, Schlörmann W, Birringer M, Glei M (2012) In vitro fermented nuts exhibit chemopreventive effects in HT29 colon cancer cells. Br J Nutr 108:1177–1186CrossRef

23.

Schlörmann W, Hiller B, Jahns F, Zoger R, Hennemeier I, Wilhelm A, Lindhauer MG, Glei M (2012) Chemopreventive effects of in vitro digested and fermented bread in human colon cells. Eur J Nutr 51:827–839CrossRef

24.

Stein K, Borowicki A, Scharlau D, Scheu K, Brenner-Weiss G, Obst U, Hollmann J, Lindhauer M, Wachter N, Glei M (2011) Modification of an in vitro model simulating the whole digestive process to investigate cellular endpoints of chemoprevention. Br J Nutr 105:678–687CrossRef

25.

Klein A, Friedrich U, Vogelsang H, Jahreis G (2008) Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 62:584–593CrossRef

26.

Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509

27.

Keller S, Jahreis G (2004) Determination of underivatised sterols and bile acid trimethyl silyl ether methyl esters by gas chromatography–mass spectrometry-single ion monitoring in faeces. J Chromatogr B Analyt Technol Biomed Life Sci 813:199–207CrossRef

28.

Papastergiadis A, Mubiru E, Van Langenhove H, De MB (2012) Malondialdehyde measurement in oxidized foods: evaluation of the spectrophotometric thiobarbituric acid reactive substances (TBARS) test in various foods. J Agric Food Chem 60:9589–9594CrossRef

29.

Fischer S, Glei M (2013) Health-potential of nuts. Ernaehrungs Umsch Int 60:206–215. doi:10.4455/eu.2013.040

30.

Ros E (2009) Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 89:1649S–1656SCrossRef

31.

Borowicki A, Stein K, Scharlau D, Scheu K, Brenner-Weiss G, Obst U, Hollmann J, Lindhauer M, Wachter N, Glei M (2010) Fermented wheat aleurone inhibits growth and induces apoptosis in human HT29 colon adenocarcinoma cells. Br J Nutr 103:360–369CrossRef

32.

Glei M, Hofmann T, Kuster K, Hollmann J, Lindhauer MG, Pool-Zobel BL (2006) Both wheat (Triticum aestivum) bran arabinoxylans and gut flora-mediated fermentation products protect human colon cells from genotoxic activities of 4-hydroxynonenal and hydrogen peroxide. J Agric Food Chem 54:2088–2095CrossRef

33.

Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682:39–53CrossRef

34.

Mandalari G, Nueno-Palop C, Bisignano G, Wickham MS, Narbad A (2008) Potential prebiotic properties of almond (Amygdalus communis L.) seeds. Appl Environ Microbiol 74:4264–4270CrossRef

35.

Kepler CR, Hirons KP, McNeill JJ, Tove SB (1966) Intermediates and products of the biohydrogenation of linoleic acid by Butyrinvibrio fibrisolvens. J Biol Chem 241:1350–1354

36.

Palmquist DL, Lock AL, Shingfield KJ, Bauman DE (2005) Biosynthesis of conjugated linoleic acid in ruminants and humans. Adv Food Nutr Res 50:179–217CrossRef

37.

Coakley M, Johnson MC, McGrath E, Rahman S, Ross RP, Fitzgerald GF, Devery R, Stanton C (2006) Intestinal bifidobacteria that produce trans-9, trans-11 conjugated linoleic acid: a fatty acid with antiproliferative activity against human colon SW480 and HT-29 cancer cells. Nutr Cancer 56:95–102CrossRef

38.

Ogawa J, Kishino S, Ando A, Sugimoto S, Mihara K, Shimizu S (2005) Production of conjugated fatty acids by lactic acid bacteria. J Biosci Bioeng 100:355–364CrossRef

39.

Chin SF, Storkson JM, Albright KJ, Pariza MW (1994) Conjugated linoleic-acid (9,11-octadecadienoic and 10,12-octadecadienoic acid) is produced in conventional but not germ-free rats fed linoleic-acid. J Nutr 124:694–701

40.

Pierre AS, Minville-Walz M, Fevre C, Hichami A, Gresti J, Pichon L, Bellenger S, Bellenger J, Ghiringhelli F, Narce M, Rialland M (2013) Trans-10, cis-12 conjugated linoleic acid induced cell death in human colon cancer cells through reactive oxygen species-mediated ER stress. Biochim Biophys Acta 1831:759–768CrossRef

41.

Bozzo F, Bocca C, Colombatto S, Miglietta A (2007) Antiproliferative effect of conjugated linoleic acid in caco-2 cells: involvement of PPARgamma and APC/beta-catenin pathways. Chem Biol Interact 169:110–121CrossRef

42.

Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, Kwon DY, Park JH (2005) Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 11:5142–5150CrossRef

43.

Kamlage B, Hartmann L, Gruhl B, Blaut M (1999) Intestinal microorganisms do not supply associated gnotobiotic rats with conjugated linoleic acid. J Nutr 129:2212–2217

44.

Herbel BK, McGuire MK, McGuire MA, Shultz TD (1998) Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin Nutr 67:332–337

45.

Abdelmagid SA, Clarke SE, Wong J, Roke K, Nielsen D, Badawi A, El-Sohemy A, Mutch DM, Ma DWL (2013) Plasma concentration of cis9trans11 CLA in males and females is influenced by SCD1 genetic variations and hormonal contraceptives: a cross-sectional study. Nutr Metab 10:1–9CrossRef

46.

Tong JL, Ran ZH, Shen J, Fan GQ, Xiao SD (2008) Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Yonsei Med J 49:792–803CrossRef

47.

Zampa A, Silvi S, Fabiani R, Morozzi G, Orpianesi C, Cresci A (2004) Effects of different digestible carbohydrates on bile acid metabolism and SCFA production by human gut micro-flora grown in an in vitro semi-continuous culture. Anaerobe 10:19–26CrossRef

48.

Elhardallou SB (1992) The bile acids binding of the fibre-rich fractions of three starchy legumes. Plant Foods Hum Nutr 42:207–218CrossRef

49.

Kim HJ, White PJ (2010) In vitro bile-acid binding and fermentation of high, medium, and low molecular weight beta-glucan. J Agric Food Chem 58:628–634CrossRef

50.

Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241–259CrossRef

51.

Ayala A, Munoz MF, Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438CrossRef

52.

Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128CrossRef

53.

Hendrickse CW, Kelly RW, Radley S, Donovan IA, Keighley MR, Neoptolemos JP (1994) Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg 81:1219–1223CrossRef

54.

Leuratti C, Watson MA, Deag EJ, Welch A, Singh R, Gottschalg E, Marnett LJ, Atkin W, Day NE, Shuker DE, Bingham SA (2002) Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. Cancer Epidemiol Biomarkers Prev 11:267–273

55.

Jenkins DJ, Kendall CW, Marchie A, Josse AR, Nguyen TH, Faulkner DA, Lapsley KG, Blumberg J (2008) Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr 138:908–913

56.

Durak I, Koksal I, Kacmaz M, Buyukkocak S, Cimen BM, Ozturk HS (1999) Hazelnut supplementation enhances plasma antioxidant potential and lowers plasma cholesterol levels. Clin Chim Acta 284:113–115CrossRef

57.

Xie LM, Ge YY, Huang X, Zhang YQ, Li JX (2015) Effects of fermentable dietary fiber supplementation on oxidative and inflammatory status in hemodialysis patients. Int J Clin Exp Med 8:1363–1369

58.

Erhardt JG, Lim SS, Bode JC, Bode C (1997) A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human feces. J Nutr 127:706–709

59.

Wu WT, Chen HL (2011) Konjac glucomannan and inulin systematically modulate antioxidant defense in rats fed a high-fat fiber-free diet. J Agric Food Chem 59:9194–9200CrossRef

60.

Sun J, Hu XL, Le GW, Shi YH (2010) Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation. Lett Appl Microbiol 50:264–269CrossRef

61.

Wang CH, Lai P, Chen ME, Chen HL (2008) Antioxidative capacity produced by Bifidobacterium- and Lactobacillus acidophilus-mediated fermentations of konjac glucomannan and glucomannan oligosaccharides. J Sci Food Agric 88:1294–1300CrossRef

Titel: In vitro fermentation of nuts results in the formation of butyrate and c9,t11 conjugated linoleic acid as chemopreventive metabolites
verfasst von: W. Schlörmann
M. Birringer
A. Lochner
S. Lorkowski
I. Richter
C. Rohrer
M. Glei
Publikationsdatum: 19.08.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 6/2016
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-015-1020-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

16.04.2024 | Spondylitis ankylosans | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

In vitro fermentation of nuts results in the formation of butyrate and c9,t11 conjugated linoleic acid as chemopreventive metabolites

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

l-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women

Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males

Cognitive effects following acute wild blueberry supplementation in 7- to 10-year-old children

Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: a RCT

Time-dependent cellular response in the liver and heart in a dietary-induced obese mouse model: the potential role of ER stress and autophagy

Examining techniques for measuring the effects of nutrients on mental performance and mood state

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Innere Medizin